Group B Streptococcus Vaccine Study for Pregnant Women and Their Babies

This study wants to learn more about an investigational Group B Streptococcus (GBS) vaccine given during pregnancy. The goal is to see how safe and well tolerated the vaccine is and to learn if it can protect against GBS for both pregnant women and their babies.


Why this Research Matters

GBS is a common type of bacteria that can cause complications during pregnancy and serious illness in babies. GBS can be passed from a pregnant woman to her baby during pregnancy, birth, or shortly after delivery. This study wants to learn if an investigational GBS vaccine can help protect pregnant women and their babies from GBS. An investigational vaccine is one that has not been approved by the FDA. Before joining, you will have a physical exam and a blood test to see if you are a good fit for the study. If you are eligible, you will be chosen by chance, like flipping a coin, to get the GBS vaccine or a placebo. A placebo looks like the study vaccine but has no active medicine. You and the study team will not know which vaccine you get until the study is over. You will be in the study until about six months after your baby is born. During this time, you will have about five study visits. At these visits you may have a blood test and answer questions about your health. Your baby will also be in the study until they are 12 months old and will have about four study visits. In total, you will have 9 study visits over 14 months. Some of these visits may be done by phone. You will get the study vaccine at no cost. You and your insurance are responsible for routine medical care. You and your baby will be paid up to $1,175 for being in this study.


Who can Participate

All Ages

You may be able to join if you are 18 to 49 years old, between 24 and 36 weeks pregnant with one baby, and have a healthy pregnancy without complications or concerns found on ultrasound. The study team will review all requirements with you.


Study ID

Protocol Number: 25-1080

More information available at ClinicalTrials.gov: NCT07160244


Compensation Information

Compensation
Study Payment: Compensation provided.

Meet the Team

Image of Principal Investigator

Eric Simoes, MD

Principal Investigator